Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

1.8K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.8K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

85
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Unlikely Duo: Tuberculous Lymphadenitis Leading to Secondary Amyloidosis in a Young Patient.

The Journal of the Association of Physicians of India·2026
Same author

A Rare Case of Cervicofacial Nocardiosis and Associated Mandibular Osteomyelitis: Therapeutic Challenges in a Transplant Patient.

Diseases (Basel, Switzerland)·2025
Same author

From abstract to article: publication rates of abstracts presented at the Society for Healthcare Epidemiology of America spring conference 2018 and 2021.

Infection control and hospital epidemiology·2025
Same author

<i>Candida krusei</i> Empyema: A Lung Transplant Case and Systematic Review of the Literature.

Journal of fungi (Basel, Switzerland)·2025
Same author

Tolosa-Hunt Syndrome: A Rare Case of Painful Ophthalmoplegia in a Young Female.

The Journal of the Association of Physicians of India·2025
Same author

CMV Viremia and Colitis in Simultaneous Pancreas-Kidney Transplantation.

The American journal of case reports·2025

Related Experiment Video

Updated: Sep 9, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K

Hypokalemic Paralysis Is Not Always Periodic: A Case Series.

Mohak Jain1, Gaurav Mehta1, Ajay Parmar1

  • 1Department of Medicine, Medical College Baroda, Vadodara, Gujarat, India.

Case Reports in Medicine
|September 3, 2025
PubMed
Summary

Potassium is vital for nerve and muscle function. This case series highlights hypokalemic paralysis, emphasizing prompt diagnosis and tailored prevention based on underlying causes.

Keywords:
channelopathyhypokalemic paralysisperiodic paralysisrenal tubular acidosisthyrotoxic periodic paralysis

More Related Videos

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.6K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.1K

Related Experiment Videos

Last Updated: Sep 9, 2025

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.6K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

6.1K

Area of Science:

  • Neurology
  • Endocrinology
  • Internal Medicine

Background:

  • Potassium is essential for cellular function, especially in excitable tissues like nerves and muscles.
  • Imbalances, particularly hypokalemia (low potassium), can cause serious health issues, including muscle weakness and cardiac arrhythmias.

Observation:

  • This case series details four patients experiencing hypokalemic paralysis, a condition characterized by muscle weakness due to low potassium levels.
  • The presentations and management strategies varied across the cases, underscoring the complexity of the condition.

Findings:

  • Accurate differentiation between primary and secondary causes of hypokalemia is crucial for effective treatment of hypokalemic paralysis.
  • Rapid diagnosis via laboratory tests and thorough patient history is critical for timely intervention.

Implications:

  • Acute management of hypokalemic paralysis is standardized, but long-term prevention strategies must address the root cause of hypokalemia.
  • Further research is required to develop definitive guidelines for preventing recurrent hypokalemic paralysis.